Targeting Aquaporin-4 subcellular localization to treat central nervous system edema
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Kitchen, PSalman, MM
Halsey, AM
Clarke-Bland, C
MacDonald, JA
Ishida, H
Vogel, HJ
Almutiri, S
Logan, A
Kreida, S
Al-Jubair, T
Winkel Missel, J
Gourdon, P
Törnroth-Horsefield, S
Conner, MT
Ahmed, Z
Conner, AC
Bill, RM
Issue Date
2020-05-14
Metadata
Show full item recordAbstract
© 2020 The Author(s) Swelling of the brain or spinal cord (CNS edema) affects millions of people every year. All potential pharmacological interventions have failed in clinical trials, meaning that symptom management is the only treatment option. The water channel protein aquaporin-4 (AQP4) is expressed in astrocytes and mediates water flux across the blood-brain and blood-spinal cord barriers. Here we show that AQP4 cell-surface abundance increases in response to hypoxia-induced cell swelling in a calmodulin-dependent manner. Calmodulin directly binds the AQP4 carboxyl terminus, causing a specific conformational change and driving AQP4 cell-surface localization. Inhibition of calmodulin in a rat spinal cord injury model with the licensed drug trifluoperazine inhibited AQP4 localization to the blood-spinal cord barrier, ablated CNS edema, and led to accelerated functional recovery compared with untreated animals. We propose that targeting the mechanism of calmodulin-mediated cell-surface localization of AQP4 is a viable strategy for development of CNS edema therapies.Citation
Kitchen, P., Salman, M.M., Halsey, A.M. et al.(2020) Targeting Aquaporin-4 subcellular localization to treat central nervous system edema, Cell, 181(4), pp. 784-799.e19.Publisher
ElsevierJournal
CellPubMed ID
32413299 (pubmed)Additional Links
https://www.sciencedirect.com/science/article/pii/S0092867420303305Type
Journal articleLanguage
enDescription
© 2020 The Authors. Published by Elsevier. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1016/j.cell.2020.03.037ISSN
0092-8674EISSN
1097-4172ae974a485f413a2113503eed53cd6c53
10.1016/j.cell.2020.03.037
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution 4.0 International
Related articles
- Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema.
- Authors: Kitchen P, Salman MM, Halsey AM, Clarke-Bland C, MacDonald JA, Ishida H, Vogel HJ, Almutiri S, Logan A, Kreida S, Al-Jubair T, Winkel Missel J, Gourdon P, Törnroth-Horsefield S, Conner MT, Ahmed Z, Conner AC, Bill RM
- Issue date: 2020 May 14
- Inhibiting High Mobility Group Box-1 Reduces Early Spinal Cord Edema and Attenuates Astrocyte Activation and Aquaporin-4 Expression after Spinal Cord Injury in Rats.
- Authors: Sun L, Li M, Ma X, Zhang L, Song J, Lv C, He Y
- Issue date: 2019 Feb 1
- Hypothermia increases aquaporin 4 (AQP4) plasma membrane abundance in human primary cortical astrocytes via a calcium/transient receptor potential vanilloid 4 (TRPV4)- and calmodulin-mediated mechanism.
- Authors: Salman MM, Kitchen P, Woodroofe MN, Brown JE, Bill RM, Conner AC, Conner MT
- Issue date: 2017 Nov
- Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner.
- Authors: Sun L, Li M, Ma X, Feng H, Song J, Lv C, He Y
- Issue date: 2017 Nov 25